Swipe om te navigeren naar een ander artikel
Clinical guidelines recommend chromosomal microarray analysis (CMA) for all children with autism spectrum disorders (ASDs). We explored the test’s perceived usefulness among parents of children with ASD who had undergone CMA, and received a result categorized as pathogenic, variant of uncertain significance, or negative. Fifty-seven parents participated in a semi-structured telephone interview, and 50 also completed a survey. Most parents reported that CMA was helpful for their child and family. Major themes regarding perceived usefulness were: medical care, educational and behavioral interventions, causal explanation, information for family members, and advancing knowledge. Limits to utility, uncertainties and negative outcomes were also identified. Our findings highlight the importance of considering both health and non-health related utility in genomic testing.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Agency for Healthcare Research and Quality (AHRQ). (2014). Genetic testing for developmental disabilities, intellectual disability and autism spectrum disorders. (Technical Brief). Washington DC: Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services. Retrieved from http://effectivehealthcare.ahrq.gov/ehc/products/602/2024/genetic-testing-developmental-disabilities-draft-141215.pdf.
Battaglia, A., Doccini, V., Bernardini, L., Novelli, A., Loddo, S., Capalbo, A., & Carey, J. C. (2013). Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features. European Journal of Paediatric Neurology,17(6), 589–599. CrossRefPubMed
Bazeley, P. (2007). Qualitative analysis with Nvivo. Thousand Oaks, CA: Sage Publications Ltd.
Bernard, H. R. (2013). Social research methods: Qualitative and quantitative approaches. Thousand Oaks, CA: Sage Publications.
Chao, S., Roberts, J. S., Marteau, T. M., Silliman, R., Cupples, L. A., & Green, R. C. (2008). Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL study. Alzheimer Disease and Associated Disorders,22(1), 94–97. doi: 10.1097/WAD.0b013e31815a9dcc. PubMedCentralCrossRefPubMed
Cuccaro, M. L., Czape, K., Alessandri, M., Lee, J., Deppen, A. R., Bendik, E., & Hahn, S. (2014). Genetic testing and corresponding services among individuals with autism spectrum disorder (ASD). American Journal of Medical Genetics Part A,164(10), 2592–2600. CrossRef
Hayeems, R. Z., Hoang, N., Chenier, S., Stavropoulos, D. J., Pu, S., Weksberg, R., & Shuman, C. (2014). Capturing the clinical utility of genomic testing: Medical recommendations following pediatric microarray. European Journal of Human Genetics. doi: 10.1038/ejhg.2014.260.
Heil, K. M., & Schaaf, C. P. (2013). The genetics of autism spectrum disorders—A guide for clinicians. Current Psychiatry Reports,15(1), 1–8. CrossRef
Henderson, L. B., Applegate, C. D., Wohler, E., Sheridan, M. B., Hoover-Fong, J., & Batista, D. A. (2014). The impact of chromosomal microarray on clinical management: A retrospective analysis. Genetics in Medicine,16, 657–664.
Kegley, J. (2003). An ethical imperative: Genetics education for physicians and patients. Medicine and Law,22(2), 275–283. PubMed
Khoury, M. J., McBride, C. M., Schully, S. D., Ioannidis, J. P., Feero, W. G., Janssens, A. C. J., & Cargill, M. (2010). The scientific foundation for personal genomics: Recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genetics in Medicine,11(8), 559–567. CrossRef
Lebowitz, M. S., Rosenthal, J. E., & Ahn, W. K. (2013). Effects of biological versus psychosocial explanations on stigmatization of children with ADHD. Journal of Attention Disorders. doi: 10.1177/1087054712469255.
Lenhard, W., Breitenbach, E., Ebert, H., Schindelhauer-Deutscher, H. J., & Henn, W. (2005). Psychological benefit of diagnostic certainty for mothers of children with disabilities: Lessons from down syndrome. American Journal of Medical Genetics,133A(2), 170–175. doi: 10.1002/ajmg.a.30571. CrossRefPubMed
Lipinski, S. E., Lipinski, M. J., Biesecker, L. G., & Biesecker, B. B. (2006). Uncertainty and perceived personal control among parents of children with rare chromosome conditions: The role of genetic counseling. American Journal of Medical Genetics, Part C: Seminars in Medical Genetics,142(4), 232–240. doi: 10.1002/ajmg.c.30107. CrossRef
Makela, N. L., Birch, P. H., Friedman, J. M., & Marra, C. A. (2009). Parental perceived value of a diagnosis for intellectual disability (ID): A qualitative comparison of families with and without a diagnosis for their child’s ID. American Journal of Medical Genetics. Part A,149A(11), 2393–2402. doi: 10.1002/ajmg.a.33050. CrossRefPubMed
Miles, M. B., & Huberman, A. M. (1994). Qualitative data analysis: An expanded sourcebook (2nd ed.). Thousand Oaks, CA: Sage.
Miller, D. T., Adam, M. P., Aradhya, S., Biesecker, L. G., Brothman, A. R., Carter, N. P., & Epstein, C. J. (2010a). Consensus statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. The American Journal of Human Genetics,86(5), 749–764. CrossRefPubMed
Reiff, M., & Mulchandani, S. (2015). Integrating genetics into healthcare: Implications of genomic testing for individuals with autism spectrum disorders. In E. Giarelli, & K. Fisher (Eds.), Integrated healthcare for people with autism spectrum disorders: Interdisciplinary planning and delivery of care. Springfield, IL: Charles C. Thomas, Publishers, Ltd.
Selkirk, C. G., McCarthy Veach, P., Lian, F., Schimmenti, L., & Leroy, B. S. (2009). Parents’ perceptions of autism spectrum disorder etiology and recurrence risk and effects of their perceptions on family planning: Recommendations for genetic counselors. Journal of Genetic Counseling,18(5), 507–519. doi: 10.1007/s10897-009-9233-0. CrossRefPubMed
Shen, J., Lincoln, S., & Miller, D. T. (2014). Advances in Genetic Discovery and Implications for Counseling of Patients and Families with Autism Spectrum Disorders. Current Genetic Medicine Reports,2(3), 124–134. CrossRef
Shen, J., & Miller, D. T. (2014). Advances in genetic diagnosis of autism spectrum disorders. Current Pediatrics Reports,2(2), 71–81. CrossRef
Yudell, M., Tabor, H. K., Dawson, G., Rossi, J., Newschaffer, C. J., & Working Group in Autism Risk Communication and Ethics. (2013). Priorities for autism spectrum disorder risk communication and ethics. Autism: The International Journal of Research and Practice,17(6), 701–722. doi: 10.1177/1362361312453511. CrossRef
- Parents’ Perceptions of the Usefulness of Chromosomal Microarray Analysis for Children with Autism Spectrum Disorders
Barbara A. Bernhardt
Nancy B. Spinner
Pamela L. Sankar
- Springer US